112332-97-5 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indole-3-carboxylic acid, 6-hydroxy-, methyl ester is used as a precursor in the synthesis of various drugs and pharmaceutical products. Its versatile chemical properties and potential therapeutic benefits make it an important component in the development of new medications.
Used in Anti-inflammatory Applications:
1H-Indole-3-carboxylic acid, 6-hydroxy-, methyl ester is used as an anti-inflammatory agent for its potential to reduce inflammation and alleviate associated symptoms. Its anti-inflammatory properties can be beneficial in treating various inflammatory conditions.
Used in Anti-cancer Applications:
1H-Indole-3-carboxylic acid, 6-hydroxy-, methyl ester is used as an anti-cancer agent for its potential to inhibit the growth and proliferation of cancer cells. Its anti-cancer properties can be utilized in the development of new therapeutic strategies for cancer treatment.
Used in Anti-microbial Applications:
1H-Indole-3-carboxylic acid, 6-hydroxy-, methyl ester is used as an anti-microbial agent for its potential to inhibit the growth of microorganisms, including bacteria and fungi. Its anti-microbial properties can be employed in the development of new antimicrobial drugs and treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 112332-97-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,3,3 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 112332-97:
(8*1)+(7*1)+(6*2)+(5*3)+(4*3)+(3*2)+(2*9)+(1*7)=85
85 % 10 = 5
So 112332-97-5 is a valid CAS Registry Number.
112332-97-5Relevant articles and documents
BICYCLIC AMIDES AS KINASE INHIBITORS
-
Page/Page column 74, (2010/11/08)
The invention relates to compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula I and to the use of a compound of formula I for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases.
Synthesis and pharmacological activity of metabolites of the 5-HT4 receptor antagonist SB-207266
Fedouloff, Michael,Hossner, Frank,Voyle, Martyn,Ranson, Jennie,Powles, Jenifer,Riley, Graham,Sanger, Gareth
, p. 2119 - 2128 (2007/10/03)
Three metabolites of N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2_a]indole- 10-carboxamide (SB-207266) (1) were synthesised and their pharmacological activity determined.
INTRODUCTION OF A HYDROXY GROUP ONTO 5- AND 6-POSITION OF INDOLE NUCLEUS BY FRIEDEL-CRAFTS ACYLATION AND SUBSEQUENT BAYER-VILLIGER OXIDATION
Nakatsuka, Shin-ichi,Asano, Osamu,Ueda, Kazuo,Goto, Toshio
, p. 1471 - 1474 (2007/10/02)
A hydroxy group was efficiently introduced onto 5- and 6-position of methyl 1-methylindole-3-carboxylate 1 and methyl indole-3-carboxylate 11.
